The Global Market for Intravenous Equipment is Projected to Reach US$13.2 Billion by 2022

Clinical Efficacy & Higher Bioavailability Benefits Drive Demand for Intravenous Equipment, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Intravenous Equipment market. The global market for Intravenous Equipment is projected to reach US$13.2 billion by 2022, driven by the growing management of diseases through IV drug delivery due to its numerous benefits such as higher bioavailability, safety and therapeutic effectiveness.   

Intravenous equipment is widely used in healthcare settings for accurately delivering nutrients and minerals, fluids, and drugs such as antibiotics, analgesics, and antipyretics to a patient. Technological developments in drug delivery systems, growing incidence of chronic lifestyle disorders and infectious diseases, development of advanced specialty intravenous catheters, use of biocompatible materials to manufacture components of IV systems, represent primary factors driving the importance of IV drug delivery in healthcare facilities. Aging population and increased access to hospice and end-of-life palliative care will continue to drive demand for IV equipment for drug and nutrient infusion. Implementation of a number of government initiatives will also push up adoption of intravenous management of diseases. Rise in cancer, diabetes, gastrointestinal diseases, neurological conditions and malnutrition; increase in healthcare spending and development of healthcare infrastructure represent the other macro drivers influencing market growth, especially in developing countries.  

Intravenous infusion pumps and sets represents the largest as well as the fastest growing product market, with growth governed by technological advancements, adoption of infusion solutions in home care settings, favorable reimbursement coverage, and ongoing transition from conventional insulin pumps to more advanced, tubeless pumps, such as OmniPod to ensure continuous administration of drugs to patients. Intravenous catheters comprising peripheral catheters, midline peripheral catheters, peripherally inserted central catheter, and central venous catheters, is forecast to emerge as the fastest growing market segment. From vascular or arterial line catheters designed to read blood oxygen levels directly from the patient’s arm, to epidural catheters that administer morphine drugs straight into the spinal cord to ease pain, the changing dynamics of intravenous equipment is centered upon improving the patient’s quality of life.

As stated by the new market research report on Intravenous Equipment, the United States represents the largest market worldwide. Asia-Pacific ranks as the fastest growing market with a CAGR of 7.3% over the analysis period, led by factors such as growing population and parallel increase in healthcare burden, improving healthcare infrastructure, growing per capita healthcare spending, increased acceptance of IV drug delivery supported by growing awareness over catheter maintenance and the ensuing reduction in catheter-related infections, and increased establishment of alternate care sites such as clinics, home-healthcare, and long-term care facilities.

Major players covered in the report include AngioDynamics Inc., Animas Corporation, Arcomed AG, ASCOR S.A., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, C.R. Bard Inc., F. Hoffmann-La Roche Ltd., Fresenius SE & Co. KGaA, Halyard Health Inc., Hospira Inc., Medtronic PLC,  Moog Inc., Nipro Corporation, Smiths Medical, Teleflex Inc., and Terumo Corp., among others.

The research report titled “Intravenous Equipment: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe) Asia-Pacific (China, and Rest of Asia-Pacific), Latin America and Rest of World. The report analyzes the global and regional markets by the following Product Segments - Intravenous Catheters, and Intravenous Infusion Pumps & Sets.

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.